Comment on "Peripheral T Lymphocyte Predicts the Prognosis of Gastric Cancer Patients Undergoing Radical Gastrectomy: A Multicenter Retrospective Cohort Study" [Response to Letter].
作者信息
Xiao Hua, Luo Jia
机构信息
Department of Hepatobiliary and Intestinal Surgery, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China.
Department of Gastroduodenal and Pancreatic Surgery, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China.
出版信息
J Inflamm Res. 2025 Apr 15;18:5111-5113. doi: 10.2147/JIR.S532180. eCollection 2025.
Abstract
摘要
相似文献
1
Comment on "Peripheral T Lymphocyte Predicts the Prognosis of Gastric Cancer Patients Undergoing Radical Gastrectomy: A Multicenter Retrospective Cohort Study" [Response to Letter].对《外周血T淋巴细胞预测胃癌根治术后患者的预后：一项多中心回顾性队列研究》的评论[对信件的回复]
J Inflamm Res. 2025 Apr 15;18:5111-5113. doi: 10.2147/JIR.S532180. eCollection 2025.
2
Comment on "Peripheral T Lymphocyte Predicts the Prognosis of Gastric Cancer Patients Undergoing Radical Gastrectomy: a Multicenter Retrospective Cohort Study" [Letter].对《外周血T淋巴细胞预测胃癌根治术后患者的预后：一项多中心回顾性队列研究》的评论[信函]
J Inflamm Res. 2025 Apr 3;18:4613-4614. doi: 10.2147/JIR.S523648. eCollection 2025.
3
Peripheral T Lymphocyte Predicts the Prognosis of Gastric Cancer Patients Undergoing Radical Gastrectomy: A Multicenter Retrospective Cohort Study.外周血T淋巴细胞预测胃癌根治术后患者的预后：一项多中心回顾性队列研究
J Inflamm Res. 2024 Dec 8;17:10599-10612. doi: 10.2147/JIR.S494342. eCollection 2024.
4
Lymphopenia predicts poor prognosis in older gastric cancer patients after curative gastrectomy.淋巴细胞减少症预示着根治性胃切除术后老年胃癌患者预后不良。
Geriatr Gerontol Int. 2019 Dec;19(12):1215-1219. doi: 10.1111/ggi.13794. Epub 2019 Oct 31.
5
Risk factors for early recurrence after radical gastrectomy followed by adjuvant chemotherapy for stage II or III gastric cancer: a multicenter, retrospective study.根治性胃切除术后辅助化疗治疗 II 期或 III 期胃癌早期复发的危险因素：一项多中心回顾性研究。
Jpn J Clin Oncol. 2024 Apr 6;54(4):403-415. doi: 10.1093/jjco/hyad189.
6
Effect of perioperative probiotic supplements on the short-term clinical outcomes of patients undergoing laparoscopic or robotic radical gastrectomy after neoadjuvant chemotherapy: Study protocol for a multicenter randomized controlled trial (GISSG2023 - 01 Study).围手术期补充益生菌对新辅助化疗后接受腹腔镜或机器人根治性胃切除术患者短期临床结局的影响：一项多中心随机对照试验的研究方案（GISSG2023 - 01研究）
BMC Cancer. 2025 Apr 25;25(1):776. doi: 10.1186/s12885-025-14115-x.
7
Molecular classification of gastric cancer predicts survival in patients undergoing radical gastrectomy based on project HOPE.基于 HOPE 项目的胃癌分子分类可预测接受根治性胃切除术患者的生存情况。
Gastric Cancer. 2022 Jan;25(1):138-148. doi: 10.1007/s10120-021-01242-0. Epub 2021 Sep 2.
8
[Meta-analysis of gastric stump cancer after gastrectomy for gastric cancer].[胃癌胃切除术后残胃癌的荟萃分析]
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 May 25;21(5):569-577.
9
[Real-world data analysis of 3012 patients undergoing laparoscopic radical gastrectomy in a single center over the past 12 years].[对过去12年在单一中心接受腹腔镜根治性胃切除术的3012例患者的真实世界数据分析]
Zhonghua Wei Chang Wai Ke Za Zhi. 2022 Aug 25;25(8):716-725. doi: 10.3760/cma.j.cn441530-20220613-00257.
10
Preoperative D‑dimer level and prognosis in patients diagnosed with gastric cancer and undergoing gastric cancer radical surgery: A retrospective cohort study.胃癌根治术患者术前D-二聚体水平与预后：一项回顾性队列研究
Oncol Lett. 2024 Nov 19;29(1):64. doi: 10.3892/ol.2024.14810. eCollection 2025 Jan.
本文引用的文献
1
Low Visceral Adipose Tissue Predicts the Outcome of Neoadjuvant Chemotherapy for Colorectal Liver Metastases: A Multicentre Real-World Study.低内脏脂肪组织可预测结直肠癌肝转移新辅助化疗的疗效：一项多中心真实世界研究
J Cachexia Sarcopenia Muscle. 2025 Apr;16(2):e13785. doi: 10.1002/jcsm.13785.
2
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a randomised, open-label, phase 3 trial.局部进展期胃或胃食管交界腺癌患者行D2胃切除术后围手术期或术后辅助使用奥沙利铂联合S-1与奥沙利铂联合卡培他滨的疗效比较（RESOLVE）：一项随机、开放标签、3期试验的最终报告
Lancet Oncol. 2025 Mar;26(3):312-319. doi: 10.1016/S1470-2045(24)00676-4. Epub 2025 Feb 11.
3
Peripheral T Lymphocyte Predicts the Prognosis of Gastric Cancer Patients Undergoing Radical Gastrectomy: A Multicenter Retrospective Cohort Study.外周血T淋巴细胞预测胃癌根治术后患者的预后：一项多中心回顾性队列研究
J Inflamm Res. 2024 Dec 8;17:10599-10612. doi: 10.2147/JIR.S494342. eCollection 2024.
4
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial.接受 D2 胃切除术的局部晚期胃或胃食管交界腺癌患者中，围手术期或术后辅助奥沙利铂联合 S-1 与辅助奥沙利铂联合卡培他滨的比较（RESOLVE）：一项开放标签、优效性和非劣效性、III 期随机对照临床试验。
Lancet Oncol. 2021 Aug;22(8):1081-1092. doi: 10.1016/S1470-2045(21)00297-7. Epub 2021 Jul 9.
5
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021.中国临床肿瘤学会（CSCO）：胃癌诊断与治疗临床诊疗指南，2021 年版。
Cancer Commun (Lond). 2021 Aug;41(8):747-795. doi: 10.1002/cac2.12193. Epub 2021 Jul 1.
6
Timing and site-specific trends of recurrence in patients with pathological stage II or III gastric cancer after curative gastrectomy followed by adjuvant S-1 monotherapy.根治性胃切除术后辅助 S-1 单药治疗病理分期 II 或 III 期胃癌患者的复发时间和部位特异性趋势。
Gastric Cancer. 2019 Nov;22(6):1256-1262. doi: 10.1007/s10120-019-00953-9. Epub 2019 Mar 15.
7
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.手术和术前化疗后可切除胃癌的化疗与放化疗（CRITICS）：一项国际、开放标签、随机 3 期试验。
Lancet Oncol. 2018 May;19(5):616-628. doi: 10.1016/S1470-2045(18)30132-3. Epub 2018 Apr 9.
8
Tumor-ratio-metastasis staging system as an alternative to the 7th edition UICC TNM system in gastric cancer after D2 resection--results of a single-institution study of 1343 Chinese patients.肿瘤-淋巴结-转移分期系统作为 D2 切除术后胃癌第 7 版 UICC TNM 系统的替代方案——一项单机构 1343 例中国患者研究的结果。
Ann Oncol. 2011 Sep;22(9):2049-2056. doi: 10.1093/annonc/mdq716. Epub 2011 Feb 10.
9
X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization.X-tile：一种用于生物标志物评估和基于结果的切点优化的新型生物信息学工具。
Clin Cancer Res. 2004 Nov 1;10(21):7252-9. doi: 10.1158/1078-0432.CCR-04-0713.
Zotero 插件